Szeto, C.H.; Shalata, W.; Yakobson, A.; Agbarya, A.
Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small-Cell Lung Cancer, Past, Present, and Future. J. Clin. Med. 2021, 10, 5614.
https://doi.org/10.3390/jcm10235614
AMA Style
Szeto CH, Shalata W, Yakobson A, Agbarya A.
Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small-Cell Lung Cancer, Past, Present, and Future. Journal of Clinical Medicine. 2021; 10(23):5614.
https://doi.org/10.3390/jcm10235614
Chicago/Turabian Style
Szeto, Chun Ho, Walid Shalata, Alexander Yakobson, and Abed Agbarya.
2021. "Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small-Cell Lung Cancer, Past, Present, and Future" Journal of Clinical Medicine 10, no. 23: 5614.
https://doi.org/10.3390/jcm10235614
APA Style
Szeto, C. H., Shalata, W., Yakobson, A., & Agbarya, A.
(2021). Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small-Cell Lung Cancer, Past, Present, and Future. Journal of Clinical Medicine, 10(23), 5614.
https://doi.org/10.3390/jcm10235614